Industry NewsLife Sciences SeraNovo enters license agreement with Carna Biosciences to develop an oral formulation of Carna’s kinase inhibitor
Industry NewsClinical Diagnostics FDA approves first targeted therapy to treat aggressive form of lung cancer
